Leishmaniasis in the Middle East: Incidence and Epidemiology

PLoS Neglected Tropical Diseases

Volumn 8, Issue 10, 2014, Pages

  Salam, Nasir ^a   Al Shaqha, Waleed Mohammed ^a   Azzi, Arezki ^a  

^a AL IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY IMSIU   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; GLYCOPROTEIN; GLYCOPROTEIN GP 63; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEGLUMINE ANTIMONATE; MILTEFOSINE; PAROMOMYCIN; PHOSPHATASE; PHOSPHOTRANSFERASE; SITAMAQUINE; STIBOGLUCONATE SODIUM; UNCLASSIFIED DRUG;

ARTICLE; DISEASE CARRIER; ENDEMIC DISEASE; HEALTH PROGRAM; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNITY; INCIDENCE; IRAQ; JORDAN; LEISHMANIA; LEISHMANIASIS; MIDDLE EAST; MIGRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PSYCHODIDAE; SAUDI ARABIA; SYRIAN ARAB REPUBLIC; ANIMAL; PARASITOLOGY; PHYSIOLOGY; TRANSMISSION; WORLD HEALTH ORGANIZATION;

ANIMALS; HUMANS; INCIDENCE; INSECT VECTORS; LEISHMANIA; LEISHMANIASIS; MIDDLE EAST; PSYCHODIDAE; WORLD HEALTH ORGANIZATION;

EID: 84920517953     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003208     Document Type: Article

References (48)

1. Alvar J, Yactayo S, Bern C, (2006) Leishmaniasis and poverty. Trends Parasitol 22: 552–557.
2. Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, et al. (2012) Leishmaniasis worldwide and global estimates of its incidence. PLoS ONE 7: e35671.
3. Murray HW, Berman JD, Davies CR, Saravia NG, (2005) Advances in leishmaniasis. Lancet 366: 1561–1577.
4. Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, et al. (2007) Cutaneous leishmaniasis. Lancet Infect Dis 7: 581–596.
5. Mougneau E, Bihl F, Glaichenhaus N, (2011) Cell biology and immunology of Leishmania. Immunol Rev 240: 286–296.
6. Von Stebut E, (2007) Immunology of cutaneous leishmaniasis: the role of mast cells, phagocytes and dendritic cells for protective immunity. Eur J Dermatol 17: 115–122.
7. Kaye P, Scott P, (2011) Leishmaniasis: complexity at the host-pathogen interface. Nat Rev Microbiol 9: 604–615.
8. Horta MF, Mendes BP, Roma EH, Noronha FS, Macedo JP, et al. (2012) Reactive oxygen species and nitric oxide in cutaneous leishmaniasis. J Parasitol Res 2012: 203818.
9. Stanley AC, Engwerda CR, (2007) Balancing immunity and pathology in visceral leishmaniasis. Immunol Cell Biol 85: 138–147.
10. Reithinger R, Dujardin JC, (2007) Molecular diagnosis of leishmaniasis: current status and future applications. J Clin Microbiol 45: 21–25.
11. Goto H, Lindoso JA, (2010) Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis. Expert Rev Anti Infect Ther 8: 419–433.
12. Chappuis F, Sundar S, Hailu A, Ghalib H, Rijal S, et al. (2007) Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol 5: 873–882.
13. Parsons LM, Somoskovi A, Gutierrez C, Lee E, Paramasivan CN, et al. (2011) Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities. Clin Microbiol Rev 24: 314–350.
14. Croft SL, Sundar S, Fairlamb AH, (2006) Drug resistance in leishmaniasis. Clin Microbiol Rev 19: 111–126.
15. Masmoudi A, Hariz W, Marrekchi S, Amouri M, Turki H, (2013) Old World cutaneous leishmaniasis: diagnosis and treatment. J Dermatol Case Rep 7: 31–41.
16. Ben Salah A, Ben Messaoud N, Guedri E, Zaatour A, Ben Alaya N, et al. (2013) Topical paromomycin with or without gentamicin for cutaneous leishmaniasis. N Engl J Med 368: 524–532.
17. Doha SA, Samy AM, (2010) Bionomics of phlebotomine sand flies [Diptera: Psychodidae] in the province of Al-Baha, Saudi Arabia. Mem Inst Oswaldo Cruz 105: 850–856.
18. Maroli M, Feliciangeli MD, Bichaud L, Charrel RN, Gradoni L, (2013) Phlebotomine sandflies and the spreading of leishmaniases and other diseases of public health concern. Med Vet Entomol 27: 123–147.
19. Ready PD, (2013) Biology of phlebotomine sand flies as vectors of disease agents. Annu Rev Entomol 58: 227–250.
20. Colacicco-Mayhugh MG, Grieco JP, Putnam JL, Burkett DA, Coleman RE, (2011) Impact of phlebotomine sand flies on United States military operations at Tallil Air Base, Iraq: 5. Impact of weather on sand fly activity. J Med Entomol 48: 538–545.
21. Jacobson RL, (2011) Leishmaniasis in an era of conflict in the Middle East. Vector Borne Zoonotic Dis 11: 247–258.
22. Kedzierski L, (2010) Leishmaniasis Vaccine: Where are We Today? J Glob Infect Dis 2: 177–185.
23. Singh VP, Ranjan A, Topno RK, Verma RB, Siddique NA, et al. (2010) Estimation of under-reporting of visceral leishmaniasis cases in Bihar, India. Am J Trop Med Hyg 82: 9–11.
24. AlSamarai AM, AlObaidi HS, (2009) Cutaneous leishmaniasis in Iraq. J Infect Dev Ctries 3: 123–129.
25. Gani ZH, Hassan MK, Jassim AM, (2010) Sero-epidemiological study of visceral leishmaniasis in Basrah, Southern Iraq. J Pak Med Assoc 60: 464–469.
26. Stoops CA, Heintshcel B, El-Hossary S, Kaldas RM, Obenauer PJ, et al. (2013) Sand fly surveillance and control on Camp Ramadi, Iraq, as part of a leishmaniasis control program. J Vector Ecol 38: 411–414.
27. Majeed B, Sobel J, Nawar A, Badri S, Muslim H, (2012) The persisting burden of visceral leishmaniasis in Iraq: data of the National Surveillance System, 1990–2009. Epidemiol Infect 1–4.
28. World Health Organization (2014) WHO Leishmaniasis Resource: Iraq. Available: http://www.who.int/leishmaniasis/resources/IRAQ.pdf. Accessed 29 August 2014.
29. Ashford RW, Rioux JA, Jalouk L, Khiami A, Dye C, (1993) Evidence for a long-term increase in the incidence of Leishmania tropica in Aleppo, Syria. Trans R Soc Trop Med Hyg 87: 247–249.
30. Tayeh A, Jalouk L, Cairncross S, (1997) Twenty years of cutaneous leishmaniasis in Aleppo, Syria. Trans R Soc Trop Med Hyg 91: 657–659.
31. World Health Organization (2014) WHO Leishmaniasis Resource: Syrian Arab Republic. Available: www.who.int/leishmaniasis/resources/SYRIAN_ARAB_REPUBLIC.pdf. Accessed 29 August 2014.
32. Al-Tawfiq JA, AbuKhamsin A, (2004) Cutaneous leishmaniasis: a 46-year study of the epidemiology and clinical features in Saudi Arabia [1956–2002]. Int J Infect Dis 8: 244–250.
33. Amin TT, Kaliyadan F, Al-Ajyan MI, Al-Arfaj AK, Al-mujhim MA, et al. (2012) Public awareness and attitudes towards cutaneous leishmaniasis in an endemic region in Saudi Arabia. J Eur Acad Dermatol Venereol 26: 1544–1551.
34. El-Beshbishy HA, Al-Ali KH, El-Badry AA, (2013) Molecular characterization of cutaneous leishmaniasis in Al-Madinah Al-Munawarah province, western Saudi Arabia. Int J Infect Dis 17: e334–e338.
35. El-Beshbishy HA, Al-Ali KH, El-Badry AA, (2013) Molecular characterization of Leishmania infection in sand flies from Al-madinah Al-munawarah province, western Saudi Arabia. Exp Parasitol 134: 211–215.
36. World Health Organization (2014) WHO Leishmaniasis Resource: Saudi Arabia. Available: www.who.int/leishmaniasis/resources/SAUDI_ARABIA.pdf. Accessed 29 August 2014.
37. Saliba E, Saleh N, Bisharat Z, Oumeish O, Khoury S, et al. (1993) Cutaneous leishmaniasis due to Leishmania tropica in Jordan. Trans R Soc Trop Med Hyg 87: 633.
38. Jumaian N, Kamhawi SA, Halalsheh M, Abdel-Hafez SK, (1998) Short report: outbreak of cutaneous leishmaniasis in a nonimmune population of soldiers in Wadi Araba, Jordan. Am J Trop Med Hyg 58: 160–162.
39. Khoury S, Saliba EK, Oumeish OY, (1999) Short report: outbreak of cutaneous leishmaniasis in a nonimmune population of soldiers in Wadi Araba, Jordan. Am J Trop Med Hyg 60: 520.
40. Mosleh IM, Geith E, Schonian G, Kanani KA, (2009) Two recent but temporally distinct outbreaks of cutaneous leishmaniasis among foreign workers in the Dead-Sea area of Jordan. Ann Trop Med Parasitol 103: 393–400.
41. Mosleh IM, Geith E, Natsheh L, Abdul-Dayem M, Abotteen N, (2008) Cutaneous leishmaniasis in the Jordanian side of the Jordan Valley: severe under-reporting and consequences on public health management. Trop Med Int Health 13: 855–860.
42. Saliba EK, Pratlong F, Dedet JP, Saleh N, Khoury SA, et al. (2004) Identification of Leishmania strains from Jordan. Ann Trop Med Parasitol 98: 677–683.
43. World Health Organization (2014) WHO Leishmaniasis Resource: Jordan. Available: www.who.int/leishmaniasis/resources/JORDAN.pdf
44. Dawit G, Girma Z, Simenew K, (2013) A Review on Biology, Epidemiology and Public Health Significance of Leishmaniasis. J Bacteriol Parasitol 4: 166.
45. Seaman J, Mercer AJ, Sondorp E, (1996) The epidemic of visceral leishmaniasis in western Upper Nile, southern Sudan: course and impact from 1984 to 1994. Int J Epidemiol 25: 862–871.
46. Al Hilfi TK, Lafta R, Burnham G, (2013) Health services in Iraq. Lancet 381: 939–948.
47. World Health Organization (2014) Syrian Arab Republic: Regional Situation Reports. Available: http://www.emro.who.int/syr/information-resources/regional-situation-reports.html. Accessed 29 August 2014.
48. World Health Organization (2014) Global Health Observatory Data Repository: Leishmaniasis. Available: http://apps.who.int/gho/data/node.main.NTDLEISH?lang=en. Accessed 29 August 2014.